New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

Corporate Breaking News

Home : New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

Oct 26 2020	New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
BALTIMORE, Oct. 26, 2020 /PRNewswire/ -- Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led...


Source:https://www.prnewswire.com:443/news-releases/new-landmark-study-at-um-school-of-medicine-finds-aspirin-use-reduces-risk-of-death-in-hospitalized-covid-19-patients-301158626.html

Related News
» If you own or owned an Athena Universal Life II policy issued by AXA Equitable Life Insurance Company that was subject to a cost of insurance rate increase announced in October 2015, your rights may be affected » Zonka Feedback Named 'High Performer' in Fall 2020 G2 Grid Report for Customer Experience Management Software with High Customer Satisfaction